Jacobson Pharma Overview
- Year Founded
-
2016
- Status
-
Public
- Employees
-
1,768
- Stock Symbol
-
02633
- Investments
-
9
- Share Price
-
$0.11
- (As of Friday Closing)
Jacobson Pharma General Information
Description
Jacobson Pharma Corp Ltd and its subsidiaries are principally engaged in the development, production, marketing, and sale of essential medicines and specialty drugs to both the public and private sectors. The Group's essential medicines portfolio covers various therapeutic categories such as cardiovascular, central nervous system, gastrointestinal, antidiabetic, respiratory, anti-infective, etc.; and the specialty drugs portfolio comprises biosimilars, oncology medications, and orphan drugs. Additionally, its veterinary health division supports veterinarians and veterinary clinics with several products in different therapeutic classes and pharmaceutical forms. Geographically, the Group derives maximum revenue from Hong Kong, and the rest from Macau, the Chinese Mainland, and other regions.
Contact Information
Website
www.jacobsonpharma.comCorporate Office
- Unit 2313-18, 23/F, Tower 1 Millennium City 1
- 388 Kwun Tong Road, Kwun Tong, Kowloon
- Hong Kong
- Hong Kong
Corporate Office
- Unit 2313-18, 23/F, Tower 1 Millennium City 1
- 388 Kwun Tong Road, Kwun Tong, Kowloon
- Hong Kong
- Hong Kong
Jacobson Pharma Stock Performance
As of 20-Nov-2026, Jacobson Pharma’s stock price is $0.11. Its current market cap is $227M with 2B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.11 | $0.11 | $0.11 - $0.18 | $227M | 2B | 303K | $0.02 |
Jacobson Pharma Financials Summary
As of 31-Mar-2026, Jacobson Pharma has a trailing 12-month revenue of $201M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 382,099 | 382,099 | 327,983 | 211,700 |
| Revenue | 201,101 | 201,101 | 202,340 | 187,581 |
| EBITDA | 69,039 | 69,039 | 69,824 | 57,650 |
| Net Income | 38,647 | 38,647 | 38,601 | 34,118 |
| Total Assets | 454,823 | 454,823 | 468,602 | 445,519 |
| Total Debt | 116,249 | 116,249 | 99,400 | 95,749 |
Jacobson Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jacobson Pharma Signals
Jacobson Pharma Investments & Acquisitions (9)
Jacobson Pharma’s most recent deal was a Secondary Transaction - Private with Xinlejia International for . The deal was made on 21-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Xinlejia International | 21-Nov-2023 | Secondary Transaction - Private | Media and Information Services (B2B) | ||
| Ban Loong Jacobson JBM Pharma | 15-Jun-2022 | Joint Venture | Pharmaceuticals | ||
| HMD Dentech | 13-Oct-2021 | Later Stage VC | Distributors (Healthcare) | ||
| Cellomics International | 24-Sep-2021 | Later Stage VC | Diagnostic Equipment | ||
| HMD Dentech | 23-Jan-2020 | Early Stage VC | Distributors (Healthcare) |
Jacobson Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Jacobson Pharma Exits (2)
Jacobson Pharma’s most recent exit was on 21-Nov-2023 from Xinlejia International. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Xinlejia International | 21-Nov-2023 | Completed |
|
||
| Shanghai Henlius | 01-Jan-2018 | Later Stage VC | Completed |
|
Jacobson Pharma FAQs
-
When was Jacobson Pharma founded?
Jacobson Pharma was founded in 2016.
-
Where is Jacobson Pharma headquartered?
Jacobson Pharma is headquartered in Hong Kong, Hong Kong.
-
What is the size of Jacobson Pharma?
Jacobson Pharma has 1,768 total employees.
-
What industry is Jacobson Pharma in?
Jacobson Pharma’s primary industry is Holding Companies.
-
Is Jacobson Pharma a private or public company?
Jacobson Pharma is a Public company.
-
What is Jacobson Pharma’s stock symbol?
The ticker symbol for Jacobson Pharma is 02633.
-
What is the current stock price of Jacobson Pharma?
As of 20-Nov-2026 the stock price of Jacobson Pharma is $0.11.
-
What is the current market cap of Jacobson Pharma?
The current market capitalization of Jacobson Pharma is $227M.
-
What is Jacobson Pharma’s current revenue?
The trailing twelve month revenue for Jacobson Pharma is $201M.
-
What is Jacobson Pharma’s annual earnings per share (EPS)?
Jacobson Pharma’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process